News for Vivos Therapeutics, Inc. (VVOS)

By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas

\n Vivos Therapeutics (VVOS) has signed a definitive agreement to acquire the largest sleep center operator in Nevada for up to $9 million. The Sleep Cente

Total Revenue: $15 million in 2024, up from $13.8 million in 2023, a 9% increase.Product Revenue: $7.9 million from oral appliance sales, a 26% increase from 2

Mar 31, 2025 / 09:00PM GMTOperator Good day, everyone, and welcome to the Vivos Therapeutics Full Year 2024 Earnings Conference Call. (Operator Instructions) Th

Discover key insights from Vivos Therapeutics' Q4 2024 earnings: strategic pivots, revenue growth, and expansion plans position them for a profitable 2025.

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ETCompany ParticipantsBradford Amman - CFO, Treasurer &...

Vivos Therapeutics (VVOS) delivered earnings and revenue surprises of 34.88% and 5.18%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

**media[582034]**

**media[579434]**

**media[548599]**

LITTLETON, Colo., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (”œVivos” or the ”œCompany'') ( VVOS), a leading medical device and technolog

**media[499530]**

Vivos Therapeutics announces $3.5 million stock offering

LITTLETON, Colo., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (”œVivos” or the ”œCompany'') ( VVOS), a leading medical device and technolog

Vivos Therapeutics (VVOS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

WELLINGTON, FL / ACCESSWIRE / December 17, 2024 / Cellev8 Nutrition Inc (OTC PINK:CELV), a pioneer in Superoxide Dismutase (SOD) based supplements, has announce

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ETCompany ParticipantsKirk Huntsman - Chariman &...

**media[465507]**

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 100 500 points on Thursday. The Dow traded up 1.28% to 42,032.26 while the...